SF 2214: Relating to insurance coverage for prescription insulin drugs

What it does

This bill relates to prescription insulin drugs and coverage by policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses that provides coverage for prescription drugs to cap the total amount of cost-sharing that a covered person is required to pay per prescription filled of an insulin drug to an amount not more than $75 for an up to 31-day supply of at least one type of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs.

Senate subcommittee · named February 7, 2024

• Sen. Carrie Koelker (R) · carrie.koelker@legis.iowa.gov
• Sen. Mike Klimesh (R) · mike.klimesh@legis.iowa.gov
• Sen. Sarah Trone Garriott (D) · sarah.trone.garriott@legis.iowa.gov

Lobbying · 6 for, 0 against

For: American Diabetes Association; Iowa Chapter-American Academy of Pediatrics; Iowa Medical Society; Iowa Pharmacy Association; National Association of Social Workers, Iowa Chapter; Older Iowans Legislature

In plain words

1. February 5, 2024Filed in the Senate and sent to the Commerce committee
2. February 7, 2024Senate subcommittee named: Koelker, Klimesh and Trone Garriott
3. February 15, 2024Approved by the Senate committee